A. Bagnato

A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14).

J. Sehouli, F. Cognetti, N. Colombo, 2013, Gynecologic oncology.

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

R. Latagliata, M. Breccia, G. Alimena, 2016, European journal of haematology.

Evaluation of carcinoembryonic antigen levels in gastric juice, stomach mucosa and plasma in high-risk and gastric cancer patients.

A. Bagnato, S. Guadagni, E. Sega, 1986, Oncology.

High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia.

R. Latagliata, G. Cimino, C. Santoro, 2017, Thrombosis research.

Azacitidine In The Treatment Of Ph- Myeloproliferative Neoplasms In Blastic Phase: The Experience Of Gruppo Laziale For The Study Of Ph- SMPC

M. Voso, R. Latagliata, G. Avvisati, 2013 .